Immunomodulatory antibodies
US11780929B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2021 |
| Grant date | Oct 10, 2023 |
| Priority date | — |
| Expiry date | Apr 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies specific for 4-1BB and OX40, as well as to methods for using such antibodies and therapeutic uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.